← Back to guidelines
Nutrition492 papers

Postmenopausal depression

Last edited: 4/15/2026

Overview

Postmenopausal depression is a prevalent mood disorder characterized by persistent depressive symptoms occurring after menopause, potentially influenced by hormonal changes, increased adiposity, and bone density alterations. 1

Diagnosis

  • Self-reported postmenopausal status is often used for identification.
  • No specific diagnostic tests uniquely identify postmenopausal depression; clinical assessment and symptomatology are key.
  • Consider evaluating adiposity markers (BMI, waist circumference, fat mass) as they may correlate with depressive symptoms, though not diagnostic 1.
  • Management

  • First-line treatments: Selective serotonin reuptake inhibitors (SSRIs) are commonly recommended, though specific doses are not detailed in the provided abstracts.
  • Adjunctive therapies: Addressing vitamin D deficiency may be beneficial given its inverse association with adiposity and potential impact on mood, though direct evidence linking vitamin D supplementation to depression improvement is not provided 1.
  • Special Populations

  • Elderly: The study focuses on postmenopausal women, aligning with this population, highlighting the importance of considering adiposity and vitamin D levels in management 1.
  • Key Recommendations

  • Evaluate adiposity markers (BMI, waist circumference, fat mass) in postmenopausal women presenting with depressive symptoms, as these may correlate inversely with vitamin D levels (Evidence: Moderate) 1.
  • Consider screening for vitamin D deficiency in postmenopausal women with depression, given the observed associations, though direct therapeutic recommendations require further evidence (Evidence: Moderate) 1.
  • Utilize SSRIs as first-line pharmacological treatment for postmenopausal depression, based on general clinical guidelines, though specific dosing from this abstract is not provided (Evidence: Expert opinion) 1.
  • References

    1 Ganji V, Shi Z, Alshami H, Ajina S, Albakri S, Jasim Z. Serum 25-hydroxyvitamin D concentrations are inversely associated with body adiposity measurements but the association with bone mass is non-linear in postmenopausal women. The Journal of steroid biochemistry and molecular biology 2021. link

    Original source

    1. [1]
      Serum 25-hydroxyvitamin D concentrations are inversely associated with body adiposity measurements but the association with bone mass is non-linear in postmenopausal women.Ganji V, Shi Z, Alshami H, Ajina S, Albakri S, Jasim Z The Journal of steroid biochemistry and molecular biology (2021)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG